Clinical research

Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

EuroIntervention 2011;7:307-313. DOI: 10.4244/EIJV7I3A54

James B. Hermiller
James B. Hermiller1*, MD; Eugenia Nikolsky2, MD, PhD; Alexandra J. Lansky2, MD; Robert J. Applegate3, MD; Mark Sanz4, MD; Manejeh Yaqub5, MD; Poornima Sood5, MD; Sherry Cao5, MS; Krishnankutty Sudhir5, MD, PhD; Gregg W. Stone2, MD
1. The Care Group, LLC, St. Vincent Heart Center of IN, LLC, Indianapolis, IN, USA; 2. Columbia University Medical Center, The Cardiovascular Research Foundation, New York, NY, USA; 3. Wake Forest University Health Sciences, Winston-Salem, NC, USA; 4. St.

Aims: Age is an important determinant of outcomes in patients treated with percutaneous coronary intervention (PCI). This report from the randomised multicentre SPIRIT II

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

everolimus-eluting stentpaclitaxel-eluting stentpcielderly
Read next article
Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme

Latest news